NAT2 genotyping can be used to tailor drug therapies and predict adverse drug reactions. By identifying whether a patient is a slow or fast acetylator, healthcare providers can adjust drug dosages to minimize toxicity and maximize efficacy. This personalized approach to medicine can improve treatment outcomes and reduce the incidence of adverse effects.
